Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Colorectal Neoplasms

Free Subscription 25.06.2018 1 Ann Oncol 1 Anticancer Res 3 BMC Cancer 1 Cancer 1 Cancer Res 3 Clin Cancer Res 1 Eur J Cancer 5 Eur J Surg Oncol 1 Gut 2 Int J Cancer 2 Int J Colorectal Dis 2 Int J Oncol 2 J Natl Cancer Inst 2 PLoS Comput Biol 2 PLoS Genet 3 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Ann Oncol

1. SOBRERO A, Douillard JY
   Reply to the Letter to the Editor: "The hard road to patient-centered care: 3 or 6 months of adjuvant chemotherapy for patients with stage III colon cancer?" By P. Trendsz et al.
   Ann Oncol. 2018 Jun 15. pii: 5038506. doi: 10.1093.
   PubMed     Text format    
   
   

   
   Anticancer Res

2. LING G, Lamprecht S, Shubinsky G, Osyntsov L, et al
   Mycophenolate Mofetil Alone and in Combination with Tacrolimus Inhibits the Proliferation of HT-29 Human Colonic Adenocarcinoma Cell Line and Might Interfere with Colonic Tumorigenesis.
   Anticancer Res. 2018;38:3333-3339.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

3. KOZOVSKA Z, Patsalias A, Bajzik V, Durinikova E, et al
   ALDH1A inhibition sensitizes colon cancer cells to chemotherapy.
   BMC Cancer. 2018;18:656.
   PubMed     Text format     Abstract available
   
   
4. ERNST J, Mehnert A, Dietz A, Hornemann B, et al
   Perceived stigmatization and its impact on quality of life - results from a large register-based study including breast, colon, prostate and lung cancer patients.
   BMC Cancer. 2017;17:741.
   PubMed     Text format     Abstract available
   
   
5. NEILSEN BK, Chakraborty B, McCall JL, Frodyma DE, et al
   WDR5 supports colon cancer cells by promoting methylation of H3K4 and suppressing DNA damage.
   BMC Cancer. 2018;18:673.
   PubMed     Text format     Abstract available
   
   

   
   Cancer

6. SANOFF HK, Goldberg RM, Ivanova A, O'Reilly S, et al
   Multicenter, randomized, double-blind phase 2 trial of FOLFIRI with regorafenib or placebo as second-line therapy for metastatic colorectal cancer.
   Cancer. 2018 Jun 15. doi: 10.1002/cncr.31552.
   PubMed     Text format     Abstract available
   
   

   
   Cancer Res

7. WANG X, Chan AT, Slattery ML, Chang-Claude J, et al
   Influence of smoking, body mass index and other factors on the preventive effect of nonsteroidal anti-inflammatory drugs on colorectal cancer risk.
   Cancer Res. 2018 Jun 19. pii: 0008-5472.CAN-18-0326.
   PubMed     Text format     Abstract available
   
   

   
   Clin Cancer Res

8. BIAN Z, Zhang J, Li M, Feng Y, et al
   LncRNA-FEZF1-AS1 promotes tumor proliferation and metastasis in colorectal cancer by regulating PKM2 signaling.
   Clin Cancer Res. 2018 Jun 18. pii: 1078-0432.CCR-17-2967.
   PubMed     Text format     Abstract available
   
   
9. PAKISH JB, Zhang Q, Chen Z, Liang H, et al
   Immune microenvironment in microsatellite instable endometrial cancers: Hereditary or sporadic origin matters.
   Clin Cancer Res. 2017 Mar 6. pii: clincanres.2655.2016.
   PubMed     Text format     Abstract available
   
   
10. GALLOIS C, Taieb J, Le Corre D, Le Malicot K, et al
    Prognostic value of methylator phenotype in stage III colon cancer treated with oxaliplatin-based adjuvant chemotherapy.
    Clin Cancer Res. 2018 Jun 19. pii: 1078-0432.CCR-18-0866.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Cancer

11. STOCKER G, Hacker UT, Fiteni F, John Mahachie J, et al
    Clinical consequences of chemotherapy dose reduction in obese patients with stage III colon cancer: A retrospective analysis from the PETACC 3 study.
    Eur J Cancer. 2018;99:49-57.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Surg Oncol

12. FERNANDEZ JA, Gomez-Ruiz AJ, Olivares V, Ferri B, et al
    Clinical and pathological features of "small" GIST (</=2 cm). What is their prognostic value?
    Eur J Surg Oncol. 2018;44:580-586.
    PubMed     Text format     Abstract available
    
    
13. POLOM K, Boger C, Smyth E, Marrelli D, et al
    Synchronous metastatic gastric cancer-molecular background and clinical implications with special attention to mismatch repair deficiency.
    Eur J Surg Oncol. 2018 Mar 2. pii: S0748-7983(18)30882.
    PubMed     Text format     Abstract available
    
    
14. MIZUNO T, Cloyd JM, Vicente D, Omichi K, et al
    SMAD4 gene mutation predicts poor prognosis in patients undergoing resection for colorectal liver metastases.
    Eur J Surg Oncol. 2018;44:684-692.
    PubMed     Text format     Abstract available
    
    
15. QUINTANA JM, Anton-Ladisla A, Gonzalez N, Lazaro S, et al
    Outcomes of open versus laparoscopic surgery in patients with colon cancer.
    Eur J Surg Oncol. 2018 Jun 6. pii: S0748-7983(18)31110.
    PubMed     Text format     Abstract available
    
    
16. VAN VUGT JLA, Coebergh van den Braak RRJ, Lalmahomed ZS, Vrijland WW, et al
    Impact of low skeletal muscle mass and density on short and long-term outcome after resection of stage I-III colorectal cancer.
    Eur J Surg Oncol. 2018 Jun 6. pii: S0748-7983(18)31109.
    PubMed     Text format     Abstract available
    
    

    
    Gut

17. BARENDSE RM, Musters GD, de Graaf EJR, van den Broek FJC, et al
    Randomised controlled trial of transanal endoscopic microsurgery versus endoscopic mucosal resection for large rectal adenomas (TREND Study).
    Gut. 2018;67:837-846.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

18. BOYSEN AK, Spindler KL, Hoyer M, Mortensen FV, et al
    Metastasis directed therapy for liver and lung metastases from colorectal cancer - a population based study.
    Int J Cancer. 2018 Jun 19. doi: 10.1002/ijc.31626.
    PubMed     Text format     Abstract available
    
    
19. DASHTI SG, Win AK, Hardikar SS, Glombicki SE, et al
    Physical activity and the risk of colorectal cancer in Lynch syndrome.
    Int J Cancer. 2018 Jun 14. doi: 10.1002/ijc.31611.
    PubMed     Text format     Abstract available
    
    

    
    Int J Colorectal Dis

20. BAILON-CUADRADO M, Perez-Saborido B, Sanchez-Gonzalez J, Rodriguez-Lopez M, et al
    A new dimensional-reducing variable obtained from original inflammatory scores is highly associated to morbidity after curative surgery for colorectal cancer.
    Int J Colorectal Dis. 2018 Jun 20. pii: 10.1007/s00384-018-3100.
    PubMed     Text format     Abstract available
    
    
21. LIN PY, Chiang JM, Huang HY, You JF, et al
    Various clinicopathological features of patients with metachronous colorectal cancer in relation to different diagnostic intervals.
    Int J Colorectal Dis. 2018 Jun 21. pii: 10.1007/s00384-018-3106.
    PubMed     Text format     Abstract available
    
    

    
    Int J Oncol

22. QIAN K, Huang H, Jiang J, Xu D, et al
    Identifying autophagy gene-associated module biomarkers through construction and analysis of an autophagy-mediated ceRNAceRNA interaction network in colorectal cancer.
    Int J Oncol. 2018 Jun 18. doi: 10.3892/ijo.2018.4443.
    PubMed     Text format     Abstract available
    
    
23. WANG B, Yin M, Cheng C, Jiang H, et al
    Decreased expression of miR4903p in colorectal cancer predicts poor prognosis and promotes cell proliferation and invasion by targeting RAB14.
    Int J Oncol. 2018 Jun 19. doi: 10.3892/ijo.2018.4444.
    PubMed     Text format     Abstract available
    
    

    
    J Natl Cancer Inst

24. SCHMIT SL, Edlund CK, Schumacher FR, Gong J, et al
    Novel Common Genetic Susceptibility Loci for Colorectal Cancer.
    J Natl Cancer Inst. 2018 Jun 16. pii: 5039592. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
25. MCCULLOUGH ML, Zoltick ES, Weinstein SJ, Fedirko V, et al
    Circulating Vitamin D and Colorectal Cancer Risk: An International Pooling Project of 17 Cohorts.
    J Natl Cancer Inst. 2018 Jun 14. pii: 5035027. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    

    
    PLoS Comput Biol

26. SUN JX, He Y, Sanford E, Montesion M, et al
    A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
    PLoS Comput Biol. 2018;14:e1005965.
    PubMed     Text format     Abstract available
    
    
27. GIBBONS SM, Duvallet C, Alm EJ
    Correcting for batch effects in case-control microbiome studies.
    PLoS Comput Biol. 2018;14:e1006102.
    PubMed     Text format     Abstract available
    
    

    
    PLoS Genet

28. BURNS MB, Montassier E, Abrahante J, Priya S, et al
    Colorectal cancer mutational profiles correlate with defined microbial communities in the tumor microenvironment.
    PLoS Genet. 2018;14:e1007376.
    PubMed     Text format     Abstract available
    
    
29. PAULO P, Maia S, Pinto C, Pinto P, et al
    Targeted next generation sequencing identifies functionally deleterious germline mutations in novel genes in early-onset/familial prostate cancer.
    PLoS Genet. 2018;14:e1007355.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

30. HUHN S, da Silva Filho MI, Sanmuganantham T, Pichulik T, et al
    Coding variants in NOD-like receptors: An association study on risk and survival of colorectal cancer.
    PLoS One. 2018;13:e0199350.
    PubMed     Text format     Abstract available
    
    
31. BERTAUT A, Coudert J, Bengrine L, Dancourt V, et al
    Does mammogram attendance influence participation in cervical and colorectal cancer screening? A prospective study among 1856 French women.
    PLoS One. 2018;13:e0198939.
    PubMed     Text format     Abstract available
    
    
32. SAMRAJ AN, Bertrand KA, Luben R, Khedri Z, et al
    Polyclonal human antibodies against glycans bearing red meat-derived non-human sialic acid N-glycolylneuraminic acid are stable, reproducible, complex and vary between individuals: Total antibody levels are associated with colorectal cancer risk.
    PLoS One. 2018;13:e0197464.
    PubMed     Text format     Abstract available
    
    

    
    Proc Natl Acad Sci U S A

33. NAKAMURA M, Zhang Y, Yang Y, Sonmez C, et al
    Off-tumor targets compromise antiangiogenic drug sensitivity by inducing kidney erythropoietin production.
    Proc Natl Acad Sci U S A. 2017 Oct 23. pii: 201703431.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: